William K. Storck

机构：University of Michigan · ORCID：0000-0002-8100-9191

发表论文 36 篇 · 总被引 200 次 · h-index 7

代表论文

• LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase function (2023 · JCI Insight · 被引 43)
• PROX1 is an early driver of lineage plasticity in prostate cancer (2025 · Journal of Clinical Investigation · 被引 10)
• Combined BET bromodomain and DNMT inhibition targets critical survival pathways in transdifferentiated prostate cancer (2026 · JCI Insight)
• Supplementary Data from BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program (2023)
• Supplementary Table S1 from BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program (2023)
• Supplementary Table S8-S12 from BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program (2023)